Home › Compare › BICTF vs QYLD

BICTF vs QYLD: Dividend Comparison 2026

BICTF yields 20000.00% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BICTF wins by $52481917574412746752.00M in total portfolio value
10 years
BICTF
BICTF
● Live price
20000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52481917574412746752.00M
Annual income
$51,970,745,957,167,775,000,000,000.00
Full BICTF calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — BICTF vs QYLD

📍 BICTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBICTFQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BICTF + QYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BICTF pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BICTF
Annual income on $10K today (after 15% tax)
$1,700,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,175,134,063,592,610,000,000,000.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, BICTF beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BICTF + QYLD for your $10,000?

BICTF: 50%QYLD: 50%
100% QYLD50/50100% BICTF
Portfolio after 10yr
$26240958787206373376.00M
Annual income
$25,985,372,978,583,888,000,000,000.00/yr
Blended yield
99.03%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BICTF buys
0
QYLD buys
1
PoliticianChamberTickerTypeAmountDate
Tim Moore🏢 House$QYLD▼ Sell$15,001 - $50,0002025-05-02
Tim Moore🏢 House$QYLD▲ Buy$15,001 - $50,0002025-04-07
Dwight Evans🏢 House$QYLD▼ Sell$1,001 - $15,0002022-11-14
Dwight Evans🏢 House$QYLD▼ Sell$1,001 - $15,0002020-10-29
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBICTFQYLD
Forward yield20000.00% ✓11.92%
Annual dividend / share$2.00$2.04 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$52481917574412746752.00M ✓$25.4K
Annual income after 10y$51,970,745,957,167,775,000,000,000.00 ✓$5,659.31
Total dividends collected$52448189483771600896.00M ✓$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: BICTF vs QYLD ($10,000, DRIP)

YearBICTF PortfolioBICTF Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$2,010,700$2,000,000.00$10,352$1,192.36+$2.00M → BICTF
2$377,983,225$375,831,775.70$10,830$1,347.57+$377.97M → BICTF
3$66,433,479,469$66,029,037,418.28$11,460$1,539.07+$66433.47M → BICTF
4$10,916,985,471,987$10,845,901,648,955.73$12,275$1,777.84+$10916985.46M → BICTF
5$1,677,384,363,769,318$1,665,703,189,314,291.80$13,323$2,078.95+$1677384363.76M → BICTF
6$240,985,175,079,139,100$239,190,373,809,905,920.00$14,667$2,463.34+$240985175079.12M → BICTF
7$32,373,573,631,143,694,000$32,115,719,493,809,017,000.00$16,396$2,960.57+$32373573631143.68M → BICTF
8$4,066,766,648,320,630,000,000$4,032,126,924,535,306,000,000.00$18,631$3,612.97+$4066766648320630.00M → BICTF
9$477,730,483,406,513,300,000,000$473,379,043,092,810,300,000,000.00$21,548$4,482.15+$477730483406513344.00M → BICTF
10$52,481,917,574,412,750,000,000,000$51,970,745,957,167,775,000,000,000.00$25,398$5,659.31+$52481917574412746752.00M → BICTF

BICTF vs QYLD: Complete Analysis 2026

BICTF — Stock

Biocure Technology Inc., together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab. The company is developing Interferons-ß for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular degeneration, as well as to treat a type of eye problem known as macular edema; and Filgrastim to treat neutropenia, a lack of white blood cells caused by cancer, bone marrow transplant, chemotherapy, or by other conditions. It also engages in the research and development of CAR T Cell therapy that identifies and destroys cancer cells; a foot and mouth disease vaccine; and hair growth products. The company was founded in 2005 and is headquartered in Vancouver, Canada.

Full BICTF Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this BICTF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BICTF vs SCHDBICTF vs JEPIBICTF vs OBICTF vs KOBICTF vs MAINBICTF vs XYLDBICTF vs JEPQBICTF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.